Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

500 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Monoclonal antibody therapy of kidney cancer.
Oosterwijk E, Brouwers A, Boerman OC, Larson SM, Old LJ, Mulders P, Divgi CR. Oosterwijk E, et al. Among authors: boerman oc. Cancer Treat Res. 2003;116:199-212. doi: 10.1007/978-1-4615-0451-1_12. Cancer Treat Res. 2003. PMID: 14650834 Review. No abstract available.
Radiolabeled antibodies in renal cell carcinoma.
Stillebroer AB, Oosterwijk E, Oyen WJ, Mulders PF, Boerman OC. Stillebroer AB, et al. Among authors: boerman oc. Cancer Imaging. 2007 Nov 19;7(1):179-88. doi: 10.1102/1470-7330.2007.0025. Cancer Imaging. 2007. PMID: 18055291 Free PMC article. Review.
Antibody therapy in renal cell carcinoma.
Oosterwijk E, Boerman OC, Oyen WJ, Old LJ, Mulders PF. Oosterwijk E, et al. Among authors: boerman oc. World J Urol. 2008 Apr;26(2):141-6. doi: 10.1007/s00345-008-0236-5. Epub 2008 Feb 1. World J Urol. 2008. PMID: 18239922 Free PMC article. Review.
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.
Desar IM, Stillebroer AB, Oosterwijk E, Leenders WP, van Herpen CM, van der Graaf WT, Boerman OC, Mulders PF, Oyen WJ. Desar IM, et al. Among authors: boerman oc. J Nucl Med. 2010 Nov;51(11):1707-15. doi: 10.2967/jnumed.110.078030. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956472 Free article.
Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging.
Stillebroer AB, Zegers CM, Boerman OC, Oosterwijk E, Mulders PF, O'Donoghue JA, Visser EP, Oyen WJ. Stillebroer AB, et al. Among authors: boerman oc. J Nucl Med. 2012 Jan;53(1):82-9. doi: 10.2967/jnumed.111.094896. Epub 2011 Dec 12. J Nucl Med. 2012. PMID: 22159179 Free article. Clinical Trial.
500 results